Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Jeanette Leusen received her PhD at the University of Amsterdam in 1995. Since 15 years she leads the Immunotherapy group of the Laboratory for Translational Immunology (LTI) of the University Medical Center Utrecht, where she has shown the in vivo efficacy of IgA antibodies to treat cancer for the first time 5 years ago (EMBO MM, 2013), and pursued this line of research to overcome may hurdles with a new molecule towards application, such as half-life, manufacturability, finding proper targets (Cancer Immunol Res 2015, MABs 2016 and 2018, Cancer res 2016, Br J. Haem, 2017). She receives funding from both government and charity funds (KWF, NWO, KiKa, Villa Joep) and industry (Genmab, Synthon, Medimmune, Jansen (J&J), Argenx, Nutricia, etc). She is a lead inventor on 3 patents, and co-inventor on 2 more. She is the scientific founder of a company called TigaTx (Total IgA Therapeutics), to proceed with IgA to the clinic